– Dow Jones
RBC Capital Maintains Outperform on Sunoco, Raises Price Target to $50
RBC Capital analyst Elvira Scotto maintains Sunoco (NYSE:SUN) with a Outperform and raises the price target from $48 to $50.
Related Posts
Cancer Focused Ambrx Biopharma Stock Trading Lower Today – Here’s Why
Ambrx Biopharma Inc (NASDAQ: AMAM) announced that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01, evaluating ARX517 for metastatic castration-resistant prostate cancer (mCRPC) were made available as part of the 2023 European Society of Medical Oncolog
Elon Musk’s SpaceX Reportedly Sells Bitcoin Holdings, Writes Down $373M
Aerospace technology firm SpaceX, led by renowned entrepreneur Elon Musk, has reportedly sold all of its Bitcoin (CRYPTO: BTC) holdings and written down their value by a staggering $373 million.
Here’s How Much $1000 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 3.11% on an annualized basis…